MUSC study to determine optimal dose of transcranial magnetic stimulation for MCI

With more than $3.7 million in funding from the National Institute on Aging, Medical University of South Carolina neuropsychologist Andreana Benitez, Ph.D., of the Department of Neurology in the College of Medicine will lead a phase II clinical trial to determine the optimal dose of transcranial magnetic stimulation, or TMS, needed to improve symptoms for patients with depression and mild cognitive impairment, or MCI.

Related Keywords

Mark George ,Danielle Ellis ,Stephanie Aghamoosa ,Lisa Mcteague ,National Institute On ,Department Of Psychiatry ,Brain Stimulation Lab ,College Of Health Professions ,Drug Administration ,College Of Medicine ,University Of South Carolina ,Carolina Clinical Translational Research Institute ,Department Of Neurology ,Behavioral Sciences ,National Institute ,Medical University ,South Carolina ,Andreana Benitez ,Health Professions ,South Carolina Clinical ,Translational Research Institute ,